About: Laura Soucek     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikidata:Q901, within Data Space : dbpedia.org associated with source document(s)
QRcode icon
http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FLaura_Soucek

Laura Soucek (born 1973) is a Group Leader at VHIO (the ), Research Professor at ICREA, and CEO of Peptomyc S.L. She works on the Myc oncoprotein, the deregulation of which occurs during almost all cancers. Soucek has designed a dominant negative variant, Omomyc, which allows her to investigate the benefits of inhibiting Myc in cancer.

AttributesValues
rdf:type
rdfs:label
  • Laura Soucek (es)
  • Laura Soucek (en)
rdfs:comment
  • Laura Soucek (Velletri, 1973) es una investigadora italiana, líder de grupo en el Instituto de Oncología Vall d'Hebron, profesora de investigación en ICREA (siglas en inglés para la ), y CEO de Peptomyc S.L. Trabaja con la oncoproteína Myc, que se desregula cuando el organismo sufre cáncer. Soucek ha diseñado una variante dominante negativa, Omomyc, que le permite investigar los beneficios de inhibir el Myc durante el cáncer. (es)
  • Laura Soucek (born 1973) is a Group Leader at VHIO (the ), Research Professor at ICREA, and CEO of Peptomyc S.L. She works on the Myc oncoprotein, the deregulation of which occurs during almost all cancers. Soucek has designed a dominant negative variant, Omomyc, which allows her to investigate the benefits of inhibiting Myc in cancer. (en)
foaf:name
  • Laura Soucek (en)
name
  • Laura Soucek (en)
birth place
birth place
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
sameAs
workplaces
  • Vall d'Hebron Institute of Oncology, ICREA, UAB (en)
dbp:wikiPageUsesTemplate
alma mater
influences
has abstract
  • Laura Soucek (Velletri, 1973) es una investigadora italiana, líder de grupo en el Instituto de Oncología Vall d'Hebron, profesora de investigación en ICREA (siglas en inglés para la ), y CEO de Peptomyc S.L. Trabaja con la oncoproteína Myc, que se desregula cuando el organismo sufre cáncer. Soucek ha diseñado una variante dominante negativa, Omomyc, que le permite investigar los beneficios de inhibir el Myc durante el cáncer. (es)
  • Laura Soucek (born 1973) is a Group Leader at VHIO (the ), Research Professor at ICREA, and CEO of Peptomyc S.L. She works on the Myc oncoprotein, the deregulation of which occurs during almost all cancers. Soucek has designed a dominant negative variant, Omomyc, which allows her to investigate the benefits of inhibiting Myc in cancer. (en)
institution
prov:wasDerivedFrom
page length (characters) of wiki page
alma mater
influenced by
foaf:isPrimaryTopicOf
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (61 GB total memory, 50 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software